SGLT2 inhibition with empagliflozin improves coronary microvascular function and cardiac contractility in prediabetic ob/ob−/− mice - Concepedia

Concepedia

Publication | Open Access

SGLT2 inhibition with empagliflozin improves coronary microvascular function and cardiac contractility in prediabetic ob/ob−/− mice

DOI Full Paper Access

156

Citations

65

References

2019

Year

Damilola D. Adingupu, Sven Göpel, Julia Grönros, Margareta Behrendt, Matúš Soták, Tasso Miliotis, Ulrika Dahlqvist, Li‐Ming Gan, Ann‐Cathrine Jönsson‐Rylander

Cardiovascular Diabetology

References

	Year	Citations

Page 1